During the past decade, Clinica Ars Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica Ars Medica" are "Lung Cancer" (1 trials) and "Neuroblastoma" (1 trials). Many other conditions were trialed in "Clinica Ars Medica" in a lesser frequency.

Most popular intervention types in "Clinica Ars Medica" are "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (1 trials), "etoposide" (1 trials), "radiation therapy" (1 trials), "surgical procedure" (1 trials) and "vinblastine sulfate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Ars Medica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Ars Medica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinica Ars Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Ars Medica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".